An online guide to clarify drug interactions between rifamycins and drugs commonly used in primary care. This is meant for primary care and other health professionals.
A guide for clinical services providers performing physical examinations in sexual and reproductive health settings.
This material includes resources to assist clinicians in assessing risk for TB in children. The material is also intended to help guide decision making for testing and treatment of TB infection.
The 2019 Maryland Department of Health Guidelines for Prevention and Treatment of Tuberculosis serves a resource for Maryland healthcare providers and local health departments. The guidelines were approved by TB experts and TB clinicians within Maryland.
This 90-minute video provides training on TB and the TB Tuberculin Skin Test.
In this webinar, Dr. Drew Posey shares knowledge on the US TB screening program. The webinar includes information on how US-bound immigrants and refugees are screened for TB, the effect of the screening program on US TB efforts, and how information from the overseas exam is transmitted.
In this webinar, Dr. Charles Peloquin presents information on the epidemiology of TB in the US. Dr. Peloquin also discusses emerging treatments for latent TB infection and for active TB disease.
The webinar presents information about interactions between TB medications and other drugs. This webinar is intended for physicians, nurses, and health professionals who treat and manage the care of patients with TB and LTBI.
In this webinar, Dr. Michael Lauzardo presents a brief information on the history of human trafficking. Dr. Lauzardo also shares ways to identify victims. Additionally, Dr. Lauzardo describes ways to address TB prevention and care to improve the health outcomes of victims.
In this webinar, Dr. David Ashkin presents information on the clinical significance of tuberculosis (TB) and hepatitis C virus (HCV). Dr. Ashkin also shares information on adverse effects that can occur during treatment, as well as strategies for treatment completion and optimal management of patients with HCV and TB.
